-
Iduronidase (EC 3.2.1.76, L-iduronidase, α-L-iduronidase,
laronidase), sold as Aldurazyme, is an
enzyme with the
systematic name
glycosaminoglycan α-L-iduronohydrolase...
- acid
lipase deficiency (Wolman disease/CESD)
Sebelipase alfa IV MPS I
Laronidase IV MPS II
Idursulfase IV MPS IVA
Elosulfase alfa IV MPS VI Galsulfase...
-
therapeutics for
mucopolysaccharidosis type I (MPS I), by
manufacturing laronidase (Aldurazyme,
commercialized by
Genzyme Corporation).
BioMarin was also...
-
Imiglucerase A16AB03
Agalsidase alfa A16AB04
Agalsidase beta A16AB05
Laronidase A16AB06
Sacrosidase A16AB07
Alglucosidase alfa A16AB08
Galsulfase A16AB09...
- placebo-controlled,
multinational study of
recombinant human a-L-iduronidase (
laronidase). The
Journal of Pediatrics. 144(5):581-588, 2004. Kakkis, E., McEntee...
- (1–2): 151–6. doi:10.1007/s004390051078. PMID 10480370. "Aldurazyme (
laronidase) for MPS I and
approved in
April 2003". BioMarin.
Archived from the original...
- Simon; Remmington,
Tracey (18 June 2019). "Enzyme
replacement therapy with
laronidase (Aldurazyme®) for
treating mucopolysaccharidosis type I".
Cochrane Database...
- with
other agents in 2012,
marketed by Regeneron. –
Other Aldurazyme (
Laronidase), for
hurler syndrome.
Aplenzin (Bupropion), for
depression and quit smoking...
- alpha-galactosidase A:
Fabrazyme by
Genzyme alpha-L-iduronidase: (rhIDU;
laronidase)
Aldurazyme by
BioMarin Pharmaceutical and
Genzyme N-acetylgalactosamine-4-sulfatase...
